+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A comparison of four buprenorphine dosing regimens using open-dosing procedures: Is twice-weekly dosing possible?

A comparison of four buprenorphine dosing regimens using open-dosing procedures: Is twice-weekly dosing possible?

Addiction 95(7): 1069-1077

Aims: To compare opioid withdrawal symptoms during 24-, 48-, 72- and 96-hour buprenorphine dosing regimens and to evaluate subjects' preferences for these different dosing schedules. Subjects: Fourteen opioid-dependent subjects participated in this study. They received daily sublingual maintenance doses of 4 mg/70 kg (n = 4) or 8 mg/70 kg (n = 10) of buprenorphine. Intervention: In the first study subjects received, in a random order, four dosing regimens for five repetitions of each: daily maintenance doses every 24 hours (4 or 8 mg/70 kg), double the daily maintenance dose every 48 hours (8 or 16 mg/70 kg), triple the daily maintenance dose every 72 hours (12 or 24 mg/70 kg), and quadruple the daily maintenance dose every 96 hours (16 or 32 mg/70 kg). Measures of subjective and observer opioid withdrawal symptoms were assessed prior to receipt of each dose. In a second study, subjects chose between the different dosing regimens. Findings: Some withdrawal ratings increased during the less frequent dosing schedules in the first study. In the second study, 46% of subjects preferred the quadruple-every-fourth-day dosing regimen over every other option, and only 14% preferred to be dosed daily. Conclusions: These results suggest that some opioid-dependent outpatients are willing and able to endure the withdrawal symptoms associated with less than daily dosing, and a twice-weekly dosing regimen may be possible.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 010055038

Download citation: RISBibTeXText

PMID: 10962771

DOI: 10.1046/j.1360-0443.2000.95710698.x

Related references

Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia. Current Medical Research and Opinion 22(7): 1403-1413, 2006

Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans. Drug & Alcohol Dependence 61(2): 173-181, 1 January, 2001

Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study. British Journal of Dermatology 167(3): 658-667, 2013

Comparison of the efficacy and safety of oritavancin front-loaded dosing regimens to daily dosing: an analysis of the SIMPLIFI trial. Antimicrobial Agents and ChemoTherapy 55(7): 3476-3484, 2011

Heparin dosing: a comparison of weight-based dosing vs standard dosing. Connecticut Medicine 61(2): 103-104, 1997

Hematologic response to epoetin alfa in anemic HIV-positive patients Once-weekly dosing similar to three-times weekly dosing. Blood 94(10 SUPPL 1 PART 2): 16b, Nov 15, 1999

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. Journal of Clinical Oncology 19(11): 2875-2882, 2001

Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial. Trials 8: 35, 2007

Once-weekly epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with improved quality of life in anemic HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 34(4): 368-378, 2003

Once-weekly dosing of epoetin alfa are similar to three-times-weekly dosing to improve hemoglobin levels in chemotherapy patients: Results From multicenter prospective cohort study. Journal of Clinical Oncology 23(16_suppl): 8161-8161, 2016

Once-weekly 50-mg dosing of etanercept is as effective as twice-weekly dosing in patients with ankylosing spondylitis. 2006

Once-weekly dosing of 40 000 U epoetin alfa is as effective as thrice-weekly dosing among HIV+patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 322-323, 2001

Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans. Psychopharmacology. 136(3): 217-225, Il, 1998

A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence. Clinical Pharmacology and Therapeutics 66(3): 306-314, 1999

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens. Cancer ChemoTherapy and Pharmacology 77(4): 685-692, 2016